SOPHiA GENETICS (SOPH) Income from Non-Controlling Interests (2023 - 2024)
SOPHiA GENETICS's (SOPH) quarterly Income from Non-Controlling Interests came in at $5.1 million in Q4 2024, up 20.59% year-over-year from $4.2 million in Q1 2024, and up 20.59% quarter-over-quarter from $4.2 million in Q4 2023.
Powered by 
Analysis
SOPHiA GENETICS (SOPH) Income from Non-Controlling Interests (2023 - 2024) Analysis & Trends
SOPHiA GENETICS has disclosed Income from Non-Controlling Interests across 2 years of filings, most recently posting $5.1 million for Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 44.53 Bn | 37.29 Bn | 695.95 Mn | - |
| 2 | Waystar Holding | 4.81 Bn | 4.62 Bn | 221.99 Mn | - |
| 3 | Doximity | 4.74 Bn | 4.05 Bn | 132.93 Mn | - |
| 4 | CCC Intelligent Solutions Holdings | 4.41 Bn | 4.30 Bn | 210.64 Mn | - |
| 5 | EverCommerce | 1.40 Bn | 1.27 Bn | 119.50 Mn | - |
| 6 | Schrodinger | 1.32 Bn | 904.47 Mn | 32.43 Mn | - |
| 7 | Certara | 1.21 Bn | 1.03 Bn | 58.15 Mn | - |
| 8 | GoodRx Holdings | 1.18 Bn | 887.53 Mn | 179.41 Mn | - |
| 9 | Healthstream | 853.81 Mn | 787.08 Mn | 54.72 Mn | - |
| 10 | SOPHiA GENETICS | 554.05 Mn | 446.39 Mn | 15.06 Mn | - |